# Efficacy and Safety of Upadacitinib in Inflammatory Bowel Disease

> **NCT06780683** · — · RECRUITING · sponsor: **Xiang Gao** · enrollment: 174 (estimated)

## Conditions studied

- Inflammatory Bowel Disease
- Crohn's Disease
- Ulcerative Colitis

## Interventions

- **DRUG:** Upadacitinib

## Key facts

- **NCT ID:** NCT06780683
- **Lead sponsor:** Xiang Gao
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-01-01
- **Primary completion:** 2028-12-31
- **Final completion:** 2028-12-31
- **Target enrollment:** 174 (ESTIMATED)
- **Last updated:** 2025-01-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06780683

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06780683, "Efficacy and Safety of Upadacitinib in Inflammatory Bowel Disease". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT06780683. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*